Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy
Annals of Clinical and Translational Neurology · 2025-10 · 12 (10) · 2045-2055
DOI: 10.1002/acn3.70137 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 09.07.2025. Verfasst von Lars Masanneck und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital and Medical Faculty University Hospital Düsseldorf, Düsseldorf, Germany. Hauptthemen laut MEDLINE: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Quality of Life, Smartphone, Severity of Illness Index. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the utility of smartwatch and smartphone‐based activity metrics for assessing disease severity and quality of life in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Methods
In the electronic monitoring of disease activity in patients with CIDP (EMDA‐CIDP) trial, we performed a prospective observational study from January 2023 to July 2024 at university hospitals in Düsseldorf and Münster, with an independent validation cohort in Hannover. Eligible participants were adults with CIDP on stable intravenous immunoglobulin (IVIG) therapy. Clinical evaluations included established disability scales (I‐RODS and INCAT) and quality of life assessments. Activity metrics were captured via consumer‐grade smartwatches, with adherence criteria applied to ensure data quality. A real‐world smartphone‐based cohort of 20 patients was used as a comparator.
Results
Among 46 participants (median age 64 Years [ IQR 57–69]; 24% female), smartwatch‐derived maximum daily‐step count emerged as a robust indicator of disease severity. In 43 patients meeting wearable adherence criteria, maximum daily steps showed strong correlations with clinical scores, positively with I‐ RODS (Spearman's ρ = 0.74) and inversely with INCAT (Spearman's ρ = −0.54). Additional smartwatch metrics correlated with quality of life domains, whereas smartphone‐derived metrics of a validation cohort exhibited weaker correlations.
Interpretation
These results indicate that smartwatches many patients already use can yield valuable, objective data for assessing disease status in CIDP. Integrating smartwatch‐derived metrics into clinical assessments may enhance traditional evaluations and deepen understanding of disease progression and patient quality of life. These promising results warrant additional, larger‐scale studies in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Hospital and Medical Faculty University Hospital Düsseldorf, Düsseldorf, Germany.
- Hasso Plattner Institute, Digital Engineering Faculty University of Potsdam, Potsdam, Germany.
- Department of Neurology With Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
- Department of Neurology, Hannover Medical School, Hannover, Germany.
- Brain and Mind Center, University of Sydney, Sydney, New South Wales, Australia.
- Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic.
ORCID-Profile: Lars Masanneck, Niklas Huntemann, Christina B Schroeter
Zitieren
APA
Masanneck, L., Voth, J., Gmahl, N., Jendretzky, K., Huntemann, N., Werner, N. M., Schmidt, L., Oeztuerk, M., Quint, P., Schroeter, C. B., Hartung, H. P., Skripuletz, T., Meyer Zu Hörste, G., Ruck, T., Meuth, S. G., & Pawlitzki, M. (2025). Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy. Annals of Clinical and Translational Neurology, 12(10), 2045-2055. https://doi.org/10.1002/acn3.70137
Vancouver
Masanneck L, Voth J, Gmahl N, Jendretzky K, Huntemann N, Werner NM, et al. Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy. Annals of Clinical and Translational Neurology. 2025;12(10):2045-2055. doi:10.1002/acn3.70137
BibTeX
@article{Masanneck2025,
author = {Masanneck, Lars and Voth, Jan and Gmahl, Noëmi and Jendretzky, Konstantin and Huntemann, Niklas and Werner, Noah M and Schmidt, Linea and Oeztuerk, Menekse and Quint, Paula and Schroeter, Christina B and Hartung, Hans Peter and Skripuletz, Thomas and Meyer Zu Hörste, Gerd and Ruck, Tobias and Meuth, Sven G and Pawlitzki, Marc},
title = {Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
volume = {12},
number = {10},
pages = {2045--2055},
doi = {10.1002/acn3.70137}
}
EUVIMED